Omicron: Moderna booster jabs 37% effective

Moderna is 37 percent effective against Omicron

Results from Moderna’s early trial to build an Omicron-specific booster dose have shown that the prototype of the authorised booster vaccine is 37 percent effective against Omicron. A higher formulated dose was found to be approximately 83 percent more efficacious compared with pre-boost levels

```

Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```